Advertisement
Screener

RA PHARMACEUTICALS, INC. Revenue

RA PHARMACEUTICALS, INC. Revenue

RA PHARMACEUTICALS, INC. reported Revenue of $2.50 million for the 3-month period ending 2018-12-31, per its 10-K filed 2019-03-07.

Discontinued › Income Statement › Revenue

us-gaap:Revenues · last filed 2019-03-07

  • RA PHARMACEUTICALS, INC. revenues for the quarter ending 2018-12-31 was $2.50M.
  • RA PHARMACEUTICALS, INC. revenues for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
  • RA PHARMACEUTICALS, INC. revenues for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
  • RA PHARMACEUTICALS, INC. revenues for the quarter ending 2016-06-30 was $3.04M, a 129.22% increase year-over-year.
  • RA PHARMACEUTICALS, INC. revenues for fiscal 2018 was $2.50M.
  • RA PHARMACEUTICALS, INC. revenues for fiscal 2016 was $4.93M, a 20.37% increase from fiscal 2015.
  • RA PHARMACEUTICALS, INC. revenues for fiscal 2015 was $4.09M, a 15.24% decline from fiscal 2014.
  • RA PHARMACEUTICALS, INC. revenues for fiscal 2014 was $4.83M.
Period endRevenues 3 monthRevenues 6 monthRevenues 9 monthRevenues 12 month
2018-12-31$2.50M
10-K · filed 2019-03-07
$2.50M
10-K · filed 2019-03-07
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$0.00
derived: sum of 2 quarters · filed 2018-03-14
$3.04M
derived: sum of 3 quarters · filed 2018-03-14
$4.93M
10-K · filed 2018-03-14
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$3.04M
derived: sum of 2 quarters · filed 2018-03-14
$4.93M
10-Q · filed 2017-11-09
$5.75M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30$3.04M
10-K · filed 2018-03-14
$4.93M
10-Q · filed 2017-08-09
$5.75M
derived: sum of 3 quarters · filed 2018-03-14
$6.84M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31$1.88M
10-K · filed 2018-03-14
$2.71M
derived: sum of 2 quarters · filed 2018-03-14
$3.80M
derived: sum of 3 quarters · filed 2018-03-14
$5.13M
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31$821.00K
10-K · filed 2017-03-06
$1.92M
derived: sum of 2 quarters · filed 2017-03-06
$3.25M
derived: sum of 3 quarters · filed 2017-03-06
$4.09M
10-K · filed 2018-03-14
2015-09-30$1.10M
10-K · filed 2017-03-06
$2.42M
derived: sum of 2 quarters · filed 2017-03-06
$3.27M
10-Q · filed 2016-11-29
2015-06-30$1.33M
10-K · filed 2017-03-06
$2.18M
derived: sum of 2 quarters · filed 2017-03-06
2015-03-31$849.00K
10-K · filed 2017-03-06
2014-12-31$4.83M
10-K · filed 2017-03-06